Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
CytoSorbents Corporation logo

CytoSorbents Corporation

Sector: Healthcare   

Industry: Diagnostics & Research

0.95
 
USD
  
0.02
  
(2.16%)
Optionable: Yes  Market Cap: 48 M  90-day average vol: 173,985

Previous close: 0.9299  Open: 0.91  Bid: 0.9003  Ask: 0.95
52 week range    
0.84   
   4.29
Peers   
VIVO / 
HOLX / 
NEPH / 
BSX / 
DXR / 
Last updated: Friday 29th March 2024
44
MarketXLS Rank
60
Value
38
Technical
36
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

BSX

62 B55.742.91

DXR

0 B32.510.9222

HOLX

18 B9.873.18

NEPH

0 B-12.24.75

VASO

0 B2.80.0782

VIVO

1 B12.926.25
Financials

CTSO Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccruedPreferredStockDividends2 M9 M335731.0
AcquiredInProcessRnDIncome2 M20 M
Amortization of intangibles85600.0109600.0189000.0200000.0
Basic EPS from continuing operations-0.6-0.2-0.57-0.75
Basic EPS total-0.08-0.6-0.2-0.57-0.75
Basic weighted shares outstanding9 M14 M25 M25 M28 M31 M32 M39 M43 M44 M
Cost of sales-2 M-2 M-2 M-4 M-6 M-7 M7 M11 M11 M14 M
Depreciation-39891.0-48429.0-87397.0-126112.0-177776.0-329469.0495728.0553946.0571156.0688565.0
DepreciationAndAmortization-39891.0-48429.0-87397.0-126112.0-177776.0-329469.0495728.0553946.0571156.0688565.0
Diluted EPS total-0.75-1.29-0.33-0.46-0.32-0.56-0.6-0.2-0.57-0.75
Diluted normalized net income/share-0.57-0.75
Diluted weighted shares outstanding6 M7 M25 M26 M26 M31 M32 M39 M43 M44 M
GeneralAndAdministrativeExpense908644.0896847.01 M1 M1 M2 M24 M32 M38 M37 M
Gross operating profit511102.02 M3 M6 M10 M15 M18 M30 M32 M21 M
Income before tax-5 M-10 M-8 M-12 M-9 M-18 M-20 M-9 M-25 M-34 M
Income taxes-458279.0-385642.0-324606.0-318550.0-676739.0-619546.0-1 M-1 M-736003.0-1 M
Interest income-422843.0-310024.09301.0-231804.0-749076.0-1 M-1 M-1 M28007.0132597.0
InterestExpenseNonOperating-311000.0-199000.0
InterestIncomeOperating13 M
MiscOtherSpecialCharges160105.0-2 M1 M-175418.013 M23 M-67303.0
Net income from total operations-5 M-9 M-8 M-12 M-8 M-17 M-19 M-8 M-25 M-33 M
NetIncomeCommonStockholders-7 M-19 M-8 M-12 M-9 M-17 M-19 M-8 M-25 M-33 M
NetIncomeContinuousOperations-5 M-9 M-8 M-12 M-8 M-17 M-19 M-8 M-25 M-33 M
NetNonOperatingInterestIncomeExpense-422843.0-310024.09301.0-231804.0-749076.0-1 M-1 M-1 M28007.0132597.0
Normalized income-26 M-35 M
Operating income-5 M-7 M-9 M-11 M-25 M-38 M-19 M-10 M-23 M-32 M
Operating income before depreciation (EBITDA)-5 M-10 M-8 M-12 M-9 M-17 M-20 M-8 M-24 M-33 M
OperatingExpense-5 M-9 M-12 M-17 M-19 M-31 M37 M40 M55 M52 M
Other income net-160105.02 M-1 M175418.0-2 M-23 M67303.0
Other special charges-637000.0
OtherGandA908644.0896847.01 M1 M1 M2 M24 M32 M38 M37 M
OtherunderPreferredStockDividend2 M9 M335731.0
PreferredStockDividends2 M9 M335731.0
PromotionAndAdvertising-269000.0-142000.0-282000.0-173000.0-162000.0-212000.0314000.0285000.0615000.0582000.0
RealizedCapitalGain2 M
RentAndLandingFees-315000.0-328000.0-411000.0-473000.0-676000.0-805000.0
Research & development expense2 M2 M4 M5 M3 M8 M12 M9 M16 M15 M
ResearchExpense2 M2 M4 M5 M3 M8 M12 M9 M16 M15 M
Revenue per share-24459.0-17118.0-25573.0-35501.0-40495.0-61082.085804.0106842.0160422.0394056.0
SalariesAndWages-563040.0-696000.0-382000.0-3 M-3 M-4 M315000.0914000.01 M
Selling Gen & administrative expense3 M6 M8 M12 M16 M23 M24 M32 M38 M37 M
SellingAndMarketingExpense3 M6 M7 M11 M15 M21 M314000.0285000.0615000.0582000.0
SellingExpense3 M6 M7 M11 M15 M21 M
Special income/charges637000.0
Total Income available for interest expense (EBIT)-5 M-10 M-8 M-12 M-9 M-18 M-20 M-9 M-25 M-34 M
Total common shares outstanding299 M25 M25 M26 M29 M32 M35 M43 M44 M44 M
Total net income-5 M-9 M-8 M-12 M-8 M-17 M-19 M-8 M-25 M-33 M
Total ordinary shares54 M54 M54 M54 M54 M54 M54 M54 M54 M54 M
Total revenues2 M4 M5 M10 M15 M23 M25 M41 M43 M35 M
TotalExpenses-7 M-11 M-14 M-21 M-25 M-38 M44 M51 M66 M66 M
TotalRevenue821787.03 M4 M8 M15 M23 M25 M41 M43 M35 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University